Pacific Capital Wealth Advisors Inc. Has $7.03 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

Pacific Capital Wealth Advisors Inc. trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 18.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 51,744 shares of the financial services provider’s stock after selling 11,951 shares during the period. iShares Biotechnology ETF makes up approximately 1.8% of Pacific Capital Wealth Advisors Inc.’s holdings, making the stock its 13th largest holding. Pacific Capital Wealth Advisors Inc. owned approximately 0.09% of iShares Biotechnology ETF worth $7,029,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of IBB. International Assets Investment Management LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $76,425,000. Itau Unibanco Holding S.A. bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth $48,242,000. Tower Research Capital LLC TRC lifted its stake in shares of iShares Biotechnology ETF by 28,138.4% during the third quarter. Tower Research Capital LLC TRC now owns 98,552 shares of the financial services provider’s stock valued at $12,052,000 after acquiring an additional 98,203 shares during the period. Calamos Advisors LLC bought a new position in iShares Biotechnology ETF in the fourth quarter valued at about $7,648,000. Finally, abrdn plc acquired a new stake in iShares Biotechnology ETF in the fourth quarter worth about $5,928,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock traded down $0.69 during trading hours on Wednesday, reaching $132.59. 1,257,456 shares of the company’s stock traded hands, compared to its average volume of 1,792,102. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16. The firm’s 50 day moving average is $133.33 and its 200-day moving average is $130.34.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were given a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.38%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.